Savara Secures $150M Non-Dilutive Capital for MOLBREEVI Launch
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 27 2026
0mins
Should l Buy HTGC?
Source: Newsfilter
- Loan Agreement Amendment: Savara amended its loan agreement with Hercules Capital to access an additional $75 million upon FDA approval of MOLBREEVI, thereby strengthening its liquidity and financial stability.
- Increased Capital Availability: With the addition of the $75 million royalty financing, Savara will have approximately $150 million in non-dilutive capital to support the launch of MOLBREEVI, ensuring a competitive edge in the biopharmaceutical market.
- Market Potential Assessment: A U.S. claims analysis by Savara revealed that the autoimmune pulmonary alveolar proteinosis market is 50% larger than previously estimated, providing a robust foundation for MOLBREEVI's commercialization and expected sales growth.
- Regulatory Application Progress: Savara resubmitted the Biologics License Application for MOLBREEVI in December 2025, and if granted Priority Review, FDA approval could be achieved by Q3 2026, further accelerating the product launch timeline.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HTGC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HTGC
Wall Street analysts forecast HTGC stock price to rise
7 Analyst Rating
6 Buy
1 Hold
0 Sell
Strong Buy
Current: 16.150
Low
18.00
Averages
20.04
High
24.00
Current: 16.150
Low
18.00
Averages
20.04
High
24.00
About HTGC
Hercules Capital, Inc. is a specialty finance company. The Company is focused on providing senior secured loans to venture capital-backed and institutional-backed companies in a variety of technology and life sciences industries. It is structured as an internally managed, non-diversified, closed-end investment company. Its business objectives are to increase its net income, net investment income, and net asset value, through its investments in primarily structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It invests in a range of companies active in the technology industry sub-sectors characterized by products or services that require advanced technologies, including computer software and hardware, networking systems, semiconductors, telecommunications equipment and media, semiconductor capital equipment, information technology infrastructure, and others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Shareholder Investigation Launched: Grabar Law Office is investigating Graphic Packaging Holding Company (NYSE: GPK) for potential breaches of fiduciary duties by executives, which could lead to legal and financial risks for the company if findings are unfavorable.
- Fraud Allegations: A federal securities fraud class action against Hercules Capital Inc. (NYSE: HTGC) alleges that executives made materially false statements regarding loan origination and portfolio valuations, potentially resulting in investor losses and damaging the company's reputation and market confidence.
- Acquisition Risks Exposed: LKQ Corporation (NASDAQ: LKQ) is accused of misleading investors regarding its $2.1 billion acquisition of Uni-Select, failing to disclose significant customer losses and declining market share prior to the acquisition, which may lead to poor future financial performance.
- Court Ruling on MongoDB: The securities fraud allegations against MongoDB, Inc. (NASDAQ: MDB) survived a motion to dismiss, with the court finding that executives made misleading statements that could lead to stock price volatility and decreased investor trust.
See More
- Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, has filed a class action lawsuit against Hercules Capital and certain officers, aiming to recover damages for investors who purchased securities between May 1, 2025, and February 27, 2026, highlighting significant investor concerns regarding the company's financial transparency.
- Allegations of False Statements: The complaint alleges that Hercules Capital made materially false and misleading statements during the class period and failed to disclose adverse facts about its business and operations, potentially undermining investor confidence in the company's future prospects.
- Investor Losses: Investors are advised that those who suffered losses during the class period must apply by May 19, 2026, to be appointed as lead plaintiff, indicating that the legal risks faced by the company could adversely affect its stock price and market reputation.
- Law Firm Credentials: Bronstein, Gewirtz & Grossman, LLC is a well-regarded firm in securities fraud class actions, having recovered hundreds of millions for investors nationwide, demonstrating its strong capability and influence in protecting investor rights.
See More
- Class Action Reminder: The Schall Law Firm alerts investors of a class action lawsuit against Hercules Capital for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between May 1, 2025, and February 27, 2026, with a deadline to contact the firm by May 19, 2026, for participation.
- False Statement Allegations: The complaint alleges that Hercules Capital made false and misleading statements regarding its due diligence during the loan origination process, overstating the diligence of its portfolio valuation and misclassifying portfolio investments, which misled investors throughout the class period.
- Investor Losses: As a result of Hercules Capital's public statements being deemed false and materially misleading, investors suffered significant financial losses when the truth emerged, prompting them to seek legal recourse to recover their losses.
- Role of Law Firm: The Schall Law Firm specializes in securities class action lawsuits and shareholder rights litigation, representing investors globally, and encourages affected shareholders to proactively contact them to discuss their rights and participate in the lawsuit, even if they are not currently represented by an attorney.
See More
- Class Action Notice: Rosen Law Firm reminds investors who purchased Hercules Capital securities between May 1, 2025, and February 27, 2026, that they must apply to be lead plaintiff by May 19, 2026, to participate in the class action and seek compensation.
- Lawsuit Background: The lawsuit alleges that Hercules Capital overstated due diligence in its deal sourcing and loan origination processes, resulting in investor losses when the true details emerged, indicating serious issues with the company's financial transparency.
- Law Firm Advantage: Rosen Law Firm specializes in securities class actions and recovered over $438 million for investors in 2019 alone, showcasing its successful track record and extensive experience, prompting investors to carefully select qualified legal counsel.
- Participation Method: Investors can visit the designated website or call a toll-free number for more information, indicating that the class action has not yet been certified, allowing investors to choose to retain or change their legal representation during this period.
See More
- Class Action Reminder: The Schall Law Firm alerts investors that Hercules Capital is facing a class action lawsuit for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between May 1, 2025, and February 27, 2026, with a deadline for investor contact set for May 19, 2026.
- False Statement Allegations: The complaint alleges that Hercules made false and misleading statements regarding its due diligence during the loan origination process, overstating its portfolio valuation diligence and misclassifying investments, which led to investor losses once the truth was revealed.
- Investor Rights Protection: The Schall Law Firm specializes in securities class action lawsuits and encourages affected investors to reach out for free consultations to discuss their rights, ensuring they receive appropriate representation in the legal process.
- Lawsuit Status Explanation: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who choose not to act will remain absent class members, potentially affecting their ability to claim damages.
See More
- Class Action Notice: Rosen Law Firm reminds investors who purchased Hercules Capital securities between May 1, 2025, and February 27, 2026, that they must apply to be lead plaintiff by May 19, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Hercules Capital overstated its due diligence in deal sourcing and loan origination, resulting in misleading financial statements that caused investor losses when the truth emerged, highlighting significant misrepresentations in the company's financial reporting.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, demonstrating a strong track record; investors are advised to select experienced legal counsel to ensure their rights are protected.
- Participation Instructions: Investors can visit Rosen Law Firm's website or call toll-free at 866-767-3653 for more information on joining the class action, with no upfront fees required, ensuring that investor rights are safeguarded.
See More











